Reproductive Health Matters
Volume 16, Issue 32 , Pages 41-49 , November 2008

Cervical cancer: the sub-Saharan African perspective

References 

  1. Parkin DM, Ferlay J, Hamdi-Cherif M, et al. Cancer in Africa: Epidemiology and Prevention. IARC Scientific Publications. No.153. Lyon: IARC Press; 2003;
  2. In:  Parkin DM,  Whelan SL,  Ferlay J, et al. editor. Cancer Incidence in Five Continents, Vol VIII. IARC Scientific Publication No.155. Lyon: IARC; 2002;
  3. Wabinga HR, Parkin DW, Wabwire-Mangen F, et al. Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. British Journal of Cancer. 2000;82(9):1585–1592
  4. Chokunonga E, Levy LM, Bassett MT, et al. Zimbabwe cancer registry. In:  Parkin DM,  Whelan SL,  Ferlay J, et al. editor. Cancer Incidence in Five Continents. Vol. VIII. Lyon: IARC Press; 2002;p. 104–105
  5. Walker ARP, Michelow PM, Walker BF. Cervix cancer in African women in Durban, South Africa. International Journal Gynecology & Obstetrics. 2002;79:45–46
  6. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Practice and Research Clinical Obstetrics & Gynaecology. 2006;20(2):207–225
  7. Chokunonga E, Ramanakumar AV, Nyakabau AM, et al. Survival of cervix cancer patients in Harare, Zimbabwe, 1995–1997. British Journal of Cancer. 2003;89:65–69
  8. Parkin DM, Bray F, Ferlay J, et al. Global Cancer Statistics, 2002. CA: A Cancer Journal for Clinicians. 2005;55:74–108
  9. Odida M, Schmauz R, Lwanga SK. Grade of malignancy of cervical cancer in regions of Uganda with varying malarial endemicity. International Journal of Cancer. 2002;99:737–741
  10. Gichangi PB, Bwayo J, Estambale B, et al. Impact of HIV infection on invasive cervical cancer in Kenyan women. AIDS. 2003;17(13):1963–1968
  11. Anorlu RI, Orakwue CO, Oyeneyin L, et al. Late presentation of cervical cancer in Lagos: what is responsible?. European Journal of Gynaecological Oncology. 2004;25(6):729–732
  12. Rogo KO, Omany J, Onyango JN, et al. Carcinoma of the cervix in the African setting. International Journal of Gynecology & Obstetrics. 1990;33:249–255
  13. Chirenje ZM, Rusakaniko S, Akino V, et al. A review of cervical cancer patients presenting in Harare and Parirenyatwa Hospitals in 1998. Central African Journal of Medicine. 2000;46(10):264–267
  14. Levin V, el Gueddari B, Meghzifene A. Radiation therapy in Africa: distribution and equipment. Radiotherapy and Oncology. 1997;52:79–83
  15. Cronje HS. Screening for cervical cancer in developing countries. International Journal of Gynecology & Obstetrics. 2004;84:101–108
  16. Schmauz R, Okong P, de Villiers EM, et al. Multiple infections in cases of cervical cancer from a high incidence area in tropical Africa. International Journal of Cancer. 1989;43:805–809
  17. Serwadda D, Wawer MJ, Shah KV, et al. Use of a hybrid capture assay of self-collected vaginal swabs in rural Uganda for detection of human papillomavirus. Journal of Infectious Diseases. 1999;180(4):1316–1319
  18. Bayo S, Bosch FX, de Sanjose S, et al. Risk factors of invasive cervical cancer in Mali. International Journal of Epidemiology. 2002;31:202–209
  19. Chaouki N, Bosch FX, Munoz N, et al. The viral origin of cervical cancer in Rabat, Morocco. International Journal of Cancer. 1998;75(4):546–554
  20. Brinton LA, Reeves WC, Brenes MM, et al. Parity as a risk factor for cervical cancer. American Journal of Epidemiology. 1989;130:486–496
  21. Hildesheim A, Herrero R, Castle PE, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. British Journal Cancer. 2001;84(9):1219–1226
  22. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer. The IARC multicentre case-control study. Lancet. 2002;359:1093–1101
  23. Palacio-Mejía LS, Range-Gomez G, Hernandez Avila M, et al. Cervical cancer, a disease of poverty: mortality difference between urban and rural areas in Mexico. Salud Pública de México. 2003;45(Suppl 3):S315–S325
  24. Denny L. The prevention of cervical cancer in the developing world. BJOG. 2005;112:1204–1212
  25. Hawes SE, Kiviat NB. Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer?. Journal of National Cancer Institute. 2002;94:1592–1593
  26. Smith JS, Herrero R, Bosetti C, et al. Herpes simplex virus-2 as a human papillomavirus cofactor in the aetiology of invasive cervical cancer. Journal of National Cancer Institute. 2002;94:1604–1610
  27. Smith JS, Muñoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the aetiology of invasive cervical cancer in Brazil and the Philippines. Journal of Infectious Diseases. 2002;185:324–331
  28. Wallin KL, Wiklund F, Luostarinen T, et al. A population-based prospective study of Chlamydia trachomatis infection and cervical carcinoma. International Journal of Cancer. 2002;101:371–374
  29. Skapinyecz J, Smid I, Horvath A, et al. Pelvic inflammatory disease is a risk factor for cervical cancer. European Journal of Gynaecological Oncology. 2003;24(5):401–404
  30. Maiman M, Fruchter RG, Sedlis A, et al. Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Gynaecologic Oncology. 1998;68:233–239
  31. Wright TC, Ellerbrock TV, Chiasson MA, et al. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstetrics and Gynecology. 1994;84(4):591–597
  32. La Ruche G, You B, Mensah-Ado I, et al. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. International Journal of Cancer. 1998;76:482–486
  33. Temmerman M, Tyndall MW, Kidula N, et al. Risk factors for human papillomavirus and cervical precancerous lesions: the role of concurrent HIV-1 infection. International Journal Gynecology and Obstetrics. 1999;65:171–178
  34. Moodley M, Moodley J, Kleinschmidt I. Invasive cervical cancer and human immunodeficiency virus (HIV) infection: a South African perspective. International Journal of Gynecological Cancer. 2001;11(3):194–197
  35. Hawes SE, Critchlow CW, Faye-Niang MA, et al. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus Type 1 and 2 infections. Journal of Infectious Diseases. 2003;188:555–563
  36. Chirenje ZM. HIV and cancer of the cervix. Best Practice and Research Clinical Obstetrics Gynaecology. 2005;19(2):269–276
  37. Moodley JR, Hoffman M, Carrara H, et al. HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study. BMC Cancer. 2006;6135:
  38. Kahesa C, Mwaiselage J, Wabinga HR, et al. Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening. BioMed Central Public Health. 2008;8:262
  39. UNAIDS. AIDS Epidermic Update, 2008.
  40. Buga GA. Cervical cancer awareness and risk factors among female university students. East African Medical Journal. 1998;75(7):411–416
  41. Ajayi IO, Adewole IF. Knowledge and attitude of out patients' attendants in Nigeria to cervical cancer. Central African Journal of Medicine. 1998;44(2):41–44
  42. Wellensiek N, Moodley M, Moodley J, et al. Knowledge of cervical cancer screening and use of cervical screening facilities among women from various socioeconomic backgrounds in Durban, Kwazulu Natal, South Africa. International Journal of Gynecological Cancer. 2002;12:376–382
  43. Anorlu RI, Banjo AAF, Odoemhum C, et al. Cervical cancer and cervical cancer screening: level of awareness in women attending a primary health care facility in Lagos. Nigeria Postgraduate Medical Journal. 2000;70:25–28
  44. Gichangi P, Estamble B, Bwayo J, et al. Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya. International Journal of Gynecological Cancer. 2003;13:827–833
  45. Kidanto HL, Kilewo CD, Moshiro C. Cancer of the cervix: knowledge and attitudes of female patients admitted at Muhimbili National Hospital, Dar es Salaam. East African Medical Journal. 2002;79:467–469
  46. Tarwireyi F, Chirenje ZM, Rusakaniko S. Cancer of the cervix: knowledge, beliefs and screening behaviours of health workers in Mudzi District in Mashonaland East Province, Zimbabwe. Central African Journal of Medicine. 2003;49:83–86
  47. Ayinde OA, Omigbodun AO. Knowledge, attitude and practices related to prevention of cancer of the cervix among female health workers in Ibadan. Journal of Obstetrics and Gynaecology. 2003;23(1):55–58
  48. Anya SE, Oshi DC, Nwosu SO, et al. Knowledge, attitude, and practice of female health professionals regarding cervical cancer and Pap smear. Nigerian Journal of Medicine. 2005;14(3):283–286
  49. Clifford GM, Gallus S, Herrero R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366:991–998
  50. Kamal SM, El Sayed Khalifa K. Immune modulation by helminthic infections: worms and viral infections. Parasite Immunology. 2006;28:483–496
  51. Castellsagu X, Klaustermeier J, Carla Carrilho C, et al. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: Burden and potential for prevention. International Journal of Cancer. 2008;122:1901–1904
  52. Odida M, de Sanjosé S, Quint W, et al. Human papillomavirus type distribution in invasive cervical cancer in Uganda. BioMed Central Infectious Diseases. 2008;8:85
  53. Woto-Gaye G, Critchlow C, Kiviat N, et al. Cytological detection of cervical cancer in black Africa: what are the perspectives?. Bulletin du Cancer. 1996;83(5):407–409
  54. Anorlu RI, Rabiu KA, Abudu OO, et al. Cervical cancer screening practices among general practitioners in Lagos, Nigeria. Journal of Obstetrics and Gynaecology. 2007;27(2):181–184
  55. Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine 2006;24(Suppl 3):S3/71–S3/77.
  56. Chirenje ZM, Rusakaniko S, Kirumbi L, et al. Situation analysis for cervical cancer diagnosis and treatment in east, central and southern African countries. Bulletin of WHO. 2001;79:127–132
  57. Omigbodun AO, Ayinde OA. The management of abnormal cervical smears by Nigerian gynaecologists. International Journal Gynecology Obstetrics. 2005;88:340–341
  58. Noah HE, Iyoke CA. Abnormal Pap smears: a comparison of total abdominal hysterectomy and cone biopsy in management. Journal of Obstetrics and Gynaecology. 2006;26(1):48–51
  59. Stewart BW, Kleihues P. World Cancer Report. Lyon: IARC Press; 2003;
  60. Ashraf H. Poor nations need more help to slow growing cancer burden. Lancet. 2003;361:2209
  61. Jones S. Cancer in the developing world: a call for action. British Medical Journal. 1999;319:505–509
  62. Sepulveda C, Habiyambere V, Amandua J, et al. Quality care at end of life in Africa. British Medical Journal. 2003;327:209–213
  63. Murray SA, Grant E, Grant A, et al. Dying from cancer in developed and developing countries: lessons from two qualitative interview studies of patients and their caretakers. British Medical Journal. 2003;326:368–372
  64. Harding R, Profrene J, Higginson PJ. Palliative care in sub-Saharan Africa. Lancet. 2005;365:1971–1977
  65. Merriman A, Kaur M. Palliative care in Africa: an appraisal. Lancet. 2005;365:1909–1911

PII: S0968-8080(08)32415-X

doi: 10.1016/S0968-8080(08)32415-X

Reproductive Health Matters
Volume 16, Issue 32 , Pages 41-49 , November 2008

Article Tools